Prognostic utility of N-terminal pro B-type natriuretic peptide ratio in mixed aortic valve disease.
Jérémy BernardGuillaume JeanDavid Bienjonetti-BoudreauFrédéric JacquesLionel TastetErwan SalaunMarie-Annick ClavelPublished in: Open heart (2023)
In this series of MAVD patients, Nt-proBNP ratio was a powerful predictor of early and long-term mortality, even in patients with both non-severe AS/AR. Moreover, early-AVR may be an option for patients with Nt-proBNP ratio ≥3. Further randomised studies are needed to validate this last point.
Keyphrases
- aortic valve
- end stage renal disease
- transcatheter aortic valve replacement
- ejection fraction
- aortic stenosis
- transcatheter aortic valve implantation
- clinical trial
- newly diagnosed
- aortic valve replacement
- chronic kidney disease
- peritoneal dialysis
- open label
- early onset
- cardiovascular events
- cardiovascular disease
- study protocol
- heart failure
- double blind
- randomized controlled trial
- risk factors
- placebo controlled
- drug induced